US 9782416
Pharmaceutical formulations of potassium ATP channel openers and uses thereof
granted A61KA61K31/549A61K31/655
Quick answer
US patent 9782416 (Pharmaceutical formulations of potassium ATP channel openers and uses thereof) held by ESSENTIALIS, INC. expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ESSENTIALIS, INC.
- Grant date
- Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/549, A61K31/655, A61K9/0004, A61K9/2054